Related Experiment Video
Updated: Jun 10, 2026
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Phenobarbital versus diazepam for delirium tremens--a retrospective study
Ida Hjermø1, John Erik Anderson, Anders Fink-Jensen
1Psychiatric Centre Gentofte, Denmark.
Danish Medical Bulletin
|August 5, 2010
Summary
Phenobarbital and diazepam show similar efficacy and complication rates for treating delirium tremens (DT). Phenobarbital is a safe alternative for DT management, with some patients showing resistance to diazepam.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Delirium tremens (DT) is a critical, life-threatening condition arising from alcohol withdrawal.
- Effective treatment strategies for DT are crucial for patient outcomes.
Purpose of the Study:
- To compare the efficacy and complication rates of phenobarbital versus diazepam in treating delirium tremens.
- To evaluate phenobarbital as a potential alternative to diazepam for DT management.
Main Methods:
- Retrospective analysis of medical records from 194 patients treated for DT between 1998 and 2006.
- Comparison of treatment outcomes between patients receiving phenobarbital and those treated with diazepam.
Main Results:
- No significant differences in DT duration, hospitalization length, mortality, or pneumonia rates were observed between phenobarbital and diazepam.
- A subset of patients (9%) exhibited resistance to diazepam treatment.
- Respiratory depression occurred in 4% of phenobarbital patients and 1% of diazepam patients.
- Wernicke's encephalopathy was diagnosed in 47% of all patients.
Conclusions:
- Phenobarbital demonstrates comparable safety and effectiveness to diazepam in managing delirium tremens.
- Phenobarbital presents a viable and safe alternative treatment option for patients with DT.
Related Concept Videos
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...